Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2010
08/19/2010WO2010093859A1 Material and methods for treating developmental disorders including comorbid and idiopathic autism
08/19/2010WO2010093854A1 Controlled release pharmaceutical formulations of nitazoxanide
08/19/2010WO2010093845A1 Triazole and imidazole derivatives for use as tgr5 agonists in the treatment of diabetes and obesity
08/19/2010WO2010093839A1 Compositions and methods for extended therapy with aminopyridines
08/19/2010WO2010093838A1 Compostions and methods for using aminopyridines
08/19/2010WO2010093808A1 Selective kinase inhibitors
08/19/2010WO2010093804A1 Ace2 inhibitors for reducing gastrointestinal adverse effects of cytotoxic agents
08/19/2010WO2010093799A1 Method of treating vascular disease at a bifurcated vessel using a coated balloon
08/19/2010WO2010093789A2 Combinational compositions and methods for treatment of cancer
08/19/2010WO2010093788A2 Multiplex dicer substrate rna interference molecules having joining sequences
08/19/2010WO2010093787A2 Aminopyridine dimer compounds, compositions and related methods for neuronal nitric oxide synthase inhibition
08/19/2010WO2010093771A1 Combination vegfr2 therapy with temozolomide
08/19/2010WO2010093746A1 Sodium nitrite-containing pharmaceutical compositions
08/19/2010WO2010093736A1 Method for facilitating extinction training using d-cycloserine
08/19/2010WO2010093727A1 Quinazolinones as prolyl hydroxylase inhibitors
08/19/2010WO2010093706A2 Chemically programmed vaccination
08/19/2010WO2010093704A1 Agonists and antagonists of the s1p5 receptor, and methods of uses thereof
08/19/2010WO2010093634A1 Use of eicosapentaenoic acid ethyl ester for treating hypertriglyceridemia
08/19/2010WO2010093629A1 Par-1 antagonism in fed or antacid-dosed patients
08/19/2010WO2010093616A1 Methods for preparing s1p receptor agonists and antagonists
08/19/2010WO2010093615A2 Compounds, their syntheses, compositions, and methods to treat cancer
08/19/2010WO2010093608A1 Carba-nucleoside analogs for antiviral treatment
08/19/2010WO2010093607A1 Compounds and methods for inhibiting mmp2 and mmp9
08/19/2010WO2010093605A1 Isotopologues of thalidomide
08/19/2010WO2010093601A1 Novel sulfonic acid-containing thyromimetics, and methods for their use
08/19/2010WO2010093588A1 Methods of using and compositions comprising pde4 modulators for treatment, prevention and management of tuberculosis
08/19/2010WO2010093564A1 Valproic acid drug delivery systems and intraocular therapeutic uses thereof
08/19/2010WO2010093535A1 Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
08/19/2010WO2010093523A2 Foamable microemulsion compositions for topical administration
08/19/2010WO2010093452A2 Reducible polymers for non-viral gene delivery
08/19/2010WO2010093436A2 Toll-like receptor modulators and treatment of diseases
08/19/2010WO2010093435A1 Methods for treating non-small cell lung cancer using 5-azacytidine
08/19/2010WO2010093434A1 Isotopologues of lenalidomide
08/19/2010WO2010093425A1 Histamine h3 inverse agonists and antagonists and methods of use thereof
08/19/2010WO2010093419A1 Novel amino azaheterocyclic carboxamides
08/19/2010WO2010093382A1 Foamable benzoyl peroxide compositions for topical administration
08/19/2010WO2010093374A1 Compositions and methods for treating post-operative pain using bupivacaine and an anti-inflammatory agent
08/19/2010WO2010093359A1 Compounds for the treatment of hepatitis c
08/19/2010WO2010093341A1 C-7 isoxazolinyl quinolone/naphthyridine derivatives useful as antibacterial agents
08/19/2010WO2010093269A1 Use of a chitosan polymer for heparin neutralization
08/19/2010WO2010093263A1 Compositions and methods for the treatment and prevention of neoplastic disorders
08/19/2010WO2010093243A1 Use of a combination of diazoxide and metformin for treating obesity or obesity related disorders
08/19/2010WO2010093070A1 Pharmaceutical composition containing glur2-lacking ampar antagonist for preventing or treating psychiatric illnesses
08/19/2010WO2010093061A1 Diazepinedione derivative
08/19/2010WO2010093036A1 Cationic poly(amino acids) and uses thereof
08/19/2010WO2010092974A1 Brain tumor stem cell differentiation promoter, and therapeutic agent for brain tumor
08/19/2010WO2010092966A1 Novel triazine derivative and pharmaceutical composition containing same
08/19/2010WO2010092962A1 Hetero ring derivative
08/19/2010WO2010092941A1 Composition having vasodilation activity, process for producing same, and use of same
08/19/2010WO2010092925A1 Solid dispersion, pharmaceutical composition comprising the solid dispersion, and processes for producing the solid dispersion and the pharmaceutical composition
08/19/2010WO2010092811A1 Prophylactic or therapeutic agent for hypertension
08/19/2010WO2010092660A1 Inhibitor of casein kinase 1δ and casein kinase 1ε
08/19/2010WO2010092596A1 An oral pharmaceutical composition of dutasteride
08/19/2010WO2010092578A1 Antiseptic compositions comprising silver ions and menthol and uses thereof
08/19/2010WO2010092546A1 Androgen receptor modulating compounds, preparation and uses thereof
08/19/2010WO2010092534A1 Compositions for the treatment of aphthous stomatitis
08/19/2010WO2010092489A1 Derivatives of azaindoles as inhibitors of protein kinases abl and src
08/19/2010WO2010092485A2 Combined treatment of multiple sclerosis
08/19/2010WO2010092468A1 Composition comprising alginates and d-limonene to treat gerd and dyspepsia
08/19/2010WO2010092467A1 Medicament comprising terpenoid cholinesterase inhibitor for treatment of dismotility disorder
08/19/2010WO2010092450A1 Stable pharmaceutical composition for atherosclerosis
08/19/2010WO2010092446A1 Pharmaceutical composition comprising cilastatin, a chelating agent and opt. a penem antibiotic
08/19/2010WO2010092440A1 Cxcr2 receptor antagonists for the treatment or the prevention of insulin resistance
08/19/2010WO2010092436A1 Pharmaceutical combinations of simethicone and otilonium
08/19/2010WO2010092419A1 Combined treatment of multiple sclerosis
08/19/2010WO2010092415A1 Combination of hesperidin and antacids in the treatment of gastro-esophageal reflux disease (gerd)
08/19/2010WO2010092386A1 Crystalline polymorphic form 631
08/19/2010WO2010092371A1 Triazolo [4,3-b] pyridazine derivatives and their uses for prostate cancer
08/19/2010WO2010092342A1 Organosilicon compounds and their use as the modulators of the trpv1 receptor
08/19/2010WO2010092340A1 Fused pyridine and pyrazine derivatives as kinase inhibitors
08/19/2010WO2010092312A1 Combination of avermectins or mylbemycins with adrenergic receptors for treating or preventing skin diseases
08/19/2010WO2010092289A1 3-benzofuranyl-indol-2-one derivatives substituted at the 3 position, preparation thereof, and therapeutic use thereof
08/19/2010WO2010092288A1 Substituted 3-benzofuranyl-indol-2-one-3-acetamidopiperazine derivatives, preparation thereof, and therapeutic use thereof
08/19/2010WO2010092287A1 N-[(6-azabicyclo[3.2.1]oct-1-yl)-aryl-methyl]-benzamide derivatives, preparation thereof, and therapeutic use thereof
08/19/2010WO2010092286A1 N-[(2-azabicyclo[2.1.1]hex-1-yl]-aryl-methyl]-benzamide derivatives, preparation thereof, and therapeutic use thereof
08/19/2010WO2010092260A2 Pharmaceutical compositions of 6-oxo-6,7,8,9,10,11-hexahydrocyclohepta (c)chromen-3-yl sulfamate
08/19/2010WO2010092190A2 Prediction of response to platinum-based therapy
08/19/2010WO2010092181A1 Heterocyclic compounds, pharmaceutical compositions containing them, and their use as inhibitors of the glycine transporter 1
08/19/2010WO2010092180A1 Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy
08/19/2010WO2010092163A2 Antidiabetic medications
08/19/2010WO2010092154A1 Novel substituted indanes, method for the production thereof, and use thereof as drugs
08/19/2010WO2010092153A1 New substituted tetrahydronapthalenes, method for the production thereof, and use thereof as drugs
08/19/2010WO2010092126A1 Pharmaceutical composition comprising glucopyranosyl diphenylmethane derivatives, pharmaceutical dosage form thereof, process for their preparation and uses thereof for improved glycemic control in a patient
08/19/2010WO2010092125A1 Pharmaceutical composition comprising a sglt2 inhibitor, a dpp-iv inhibitor and optionally a further antidiabetic agent and uses thereof
08/19/2010WO2010092124A1 Pharmaceutical composition comprising linagliptin and optionally a sglt2 inhibitor, and uses thereof
08/19/2010WO2010092123A1 Sglt-2 inhibitor for treating type 1 diabetes mellitus, type 2 diabete mellitus, impaired glucose tolerance or hyperglycemia
08/19/2010WO2010092090A2 Novel salts of sitagliptin
08/19/2010WO2010092079A1 C-cbl and antagonists thereof for the treatment and diagnosis of cancer
08/19/2010WO2010092043A1 Phenoxy acetic acid derivatives
08/19/2010WO2010092041A1 [1, 2, 4] triazolo [1, 5 -a] pyridines as kinase inhibitors
08/19/2010WO2010092015A1 Urea triazololo [1, 5-a] pyridine derivatives as pi3k inhibitors
08/19/2010WO2010091996A1 2-morpholino-pyrido[3,2-d]pyrimidines
08/19/2010WO2010091981A2 Products comprising n-phenylpropenoyl amino acid amides and uses thereof
08/19/2010WO2010091979A1 Spiroindolinone pyridine derivative
08/19/2010WO2010091894A2 Methods of treating hair related conditions
08/19/2010WO2010091824A1 Fused pyrimidines as akt inhibitors
08/19/2010WO2010091808A1 Fused pyrimidines
08/19/2010WO2010091721A1 3 -substituted 1-arylsulfonylpiperidine derivatives for the treatment of pain
08/19/2010WO2010091661A1 Treatment solution for treating wounds, in particular for liquid wound treatment
08/19/2010WO2010091629A1 Chemical complexing directional separation and purification method for preparing high-purity beta-elemene raw material medicament
1 ... 2125 2126 2127 2128 2129 2130 2131 2132 2133 2134 2135 2136 2137 2138 2139 2140 2141 2142 2143 2144 2145 ... 7860